:max_bytes(133120)/d1qcnx2r3xkirq.cloudfront.net/pubmed-llm-images/41298459/bf104ed8b1c61c14053e3bad96ce75b7_wm.png)
The mechanism of luteolin suppressing pancreatic cancer (PC) via cyclin B1 (CCNB1)-mediated signalling.
Summary: Pancreatic cancer is a very tough disease to treat, and scientists are constantly looking for new ways to fight it. Recently, they tested a natural plant compound called luteolin. They discovered that luteolin can stop pancreatic cancer cells from growing and spreading. It works by blocking a specific protein (called CCNB1) that cancer cells desperately need to divide and multiply. When this protein is blocked, the cancer cells get stuck, stop growing, and eventually die. The researchers tested this in lab dishes, in tiny human tumor models, and in mice. It worked incredibly well at shrinking the tumors without causing bad side effects or damaging healthy organs. This means luteolin could be a very promising new treatment for pancreatic cancer in the future!